Allison Dorval

Insider Reports History

Location
Billerica, MA
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Allison Dorval
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Allison Dorval:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PUMA BIOTECHNOLOGY, INC. Director Common Stock 75.4K $256K $3.40 13 Jun 2025 Direct
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K $205K $16.37 05 Jun 2024 Direct
Verve Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 0 $140K $4.15 25 Jul 2025 Direct
Verve Therapeutics, Inc. Chief Financial Officer Common Stock 0 $0 $4.16 25 Jul 2025 Direct
Verve Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 0 25 Jul 2025 Direct

Insider Reports Filed by Allison Dorval

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VERV Verve Therapeutics, Inc. 25 Jul 2025 7 $0 4 Chief Financial Officer 28 Jul 2025, 17:15
PBYI PUMA BIOTECHNOLOGY, INC. 13 Jun 2025 1 -$39.5K 4 Director 17 Jun 2025, 19:43
PBYI PUMA BIOTECHNOLOGY, INC. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 20:14
VERV Verve Therapeutics, Inc. 01 Apr 2025 3 -$13.9K 4 Chief Financial Officer 03 Apr 2025, 17:00
VERV Verve Therapeutics, Inc. 08 Jan 2025 3 $0 4 Chief Financial Officer 10 Jan 2025, 09:00
VERV Verve Therapeutics, Inc. 29 Nov 2024 3 -$3.13K 4 Chief Financial Officer 03 Dec 2024, 16:30
PBYI PUMA BIOTECHNOLOGY, INC. 18 Jun 2024 1 $0 4 Director 21 Jun 2024, 21:17
PBYI PUMA BIOTECHNOLOGY, INC. 13 Jun 2024 1 -$37.1K 4 Director 17 Jun 2024, 19:18
AVTE Aerovate Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 18:00
VERV Verve Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Financial Officer 16 Feb 2024, 16:30
VERV Verve Therapeutics, Inc. 29 Nov 2023 3 -$6.34K 4 Chief Financial Officer 01 Dec 2023, 16:30
PBYI PUMA BIOTECHNOLOGY, INC. 13 Jun 2023 2 -$34.5K 4 Director 15 Jun 2023, 21:01
AVTE Aerovate Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:00
VERV Verve Therapeutics, Inc. 14 Feb 2023 1 $0 4 Chief Financial Officer 16 Feb 2023, 16:00
VERV Verve Therapeutics, Inc. 29 Nov 2022 3 -$12.2K 4 Chief Financial Officer 01 Dec 2022, 16:00
AVTE Aerovate Therapeutics, Inc. 21 Jun 2022 1 $0 4 Director 22 Jun 2022, 17:01
PBYI PUMA BIOTECHNOLOGY, INC. 14 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:16
VERV Verve Therapeutics, Inc. 11 Feb 2022 1 $0 4 Chief Financial Officer 15 Feb 2022, 08:00
VERV Verve Therapeutics, Inc. 29 Nov 2021 2 $0 4 Chief Financial Officer 30 Nov 2021, 15:26
VERV Verve Therapeutics, Inc. 29 Nov 2021 0 $0 3 Chief Financial Officer 30 Nov 2021, 15:25
AVTE Aerovate Therapeutics, Inc. 15 Jul 2021 1 $0 4 Director 19 Jul 2021, 16:28
AVTE Aerovate Therapeutics, Inc. 15 Jul 2021 0 $0 3 Director 19 Jul 2021, 16:27
PBYI PUMA BIOTECHNOLOGY, INC. 15 Jul 2021 1 $0 4 Director 16 Jul 2021, 16:46
PBYI PUMA BIOTECHNOLOGY, INC. 15 Jul 2021 0 $0 3 Director 16 Jul 2021, 16:41